2019
DOI: 10.1016/j.ejvs.2019.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Spontaneous Duodenocaval Fistula During Chemo-Radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…4,8 While 4 reported cases associate DCF with the antiangiogenic bevacizumab, this case marks the first associated with lenvatinib. 4,[9][10][11] These 2 drugs share similar mechanisms, with bevacizumab directly inhibiting VEGF and lenvatinib indirectly inhibiting VEGF through its tyrosine kinase receptor. The SE-LECT trial demonstrated 1.5% of patients on lenvatinib developed a gastrointestinal fistula or perforation.…”
Section: Discussionmentioning
confidence: 99%
“…4,8 While 4 reported cases associate DCF with the antiangiogenic bevacizumab, this case marks the first associated with lenvatinib. 4,[9][10][11] These 2 drugs share similar mechanisms, with bevacizumab directly inhibiting VEGF and lenvatinib indirectly inhibiting VEGF through its tyrosine kinase receptor. The SE-LECT trial demonstrated 1.5% of patients on lenvatinib developed a gastrointestinal fistula or perforation.…”
Section: Discussionmentioning
confidence: 99%
“…5 Tenezaca-Sari et al reported a case of a 69-year-old woman with advanced cervical squamous cell carcinoma developed a DCF after receiving palliative chemoradiation. 6 Perera et al reported 2 cases of DCFs formed after resection of retroperitoneal tumors followed by radiation therapy, noting that spontaneous formation of these fistulas mostly occurred as late complications of high-dose radiation to retroperitoneal structures. 7 To our knowledge, this is the first reported case of complex 3-way fistulas between the arterial, venous, and enteric system; specifically, iliac artery, IVC, and duodenum.…”
Section: Discussionmentioning
confidence: 99%
“…Also, atraumatic DCF has been described following chemoradiation or radiotherapy alone in retroperitoneal tumors. Bevacizumab, an antiangiogenic agent, has also been implicated as it promotes mucosal ulceration and delays its healing, facilitating fistula formation in the gastrointestinal tract [ 8 , 9 ]. Clinical presentation varies from simple abdominal pain, vomiting, and diarrhea to more severe manifestations such as fever, sepsis, and most commonly gastrointestinal bleed [ 4 , 7 ].…”
Section: Discussionmentioning
confidence: 99%